Previous research has identified caffeine - a central nervous system stimulant present in coffee, tea, and cola - as having a protective effect against Parkinson's disease.
With this in mind, the team used a "caffeine scaffold" to create eight new compounds called "bifunctional dimers," which are molecules that connect two different substances that affect dopamine-producing cells.